HeimMVIR • STO
add
Medivir AB
Við síðustu lokun
3,00 kr.
Dagbil
2,87 kr. - 3,00 kr.
Árabil
2,33 kr. - 6,76 kr.
Markaðsvirði
329,77 m. SEK
Meðalmagn
95,86 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
STO
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,10 m. | -45,00% |
Rekstrarkostnaður | 8,30 m. | 0,00% |
Nettótekjur | -36,00 m. | -35,34% |
Hagnaðarhlutfall | -3,27 þ. | -146,07% |
Hagnaður á hvern hlut | -0,32 | 31,91% |
EBITDA | -36,80 m. | -37,31% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 126,60 m. | 52,90% |
Heildareignir | 239,20 m. | 19,72% |
Heildarskuldir | 63,20 m. | 21,77% |
Eigið fé alls | 176,00 m. | — |
Útistandandi hlutabréf | 112,17 m. | — |
Eiginfjárgengi | 1,91 | — |
Arðsemi eigna | -37,08% | — |
Ávöxtun eigin fjár | -45,92% | — |
Peningaflæði
Breyting á handbæru fé
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -36,00 m. | -35,34% |
Handbært fé frá rekstri | -26,30 m. | -46,93% |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | -400,00 þ. | -300,00% |
Breyting á handbæru fé | -26,80 m. | -48,89% |
Frjálst peningaflæði | -14,04 m. | -57,95% |
Um
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Framkvæmdastjóri
Stofnsett
1988
Vefsvæði
Starfsfólk
10
